DMPV
CALA

Delphi Management Partners VIII’s Calithera Biosciences, Inc CALA Stock Holding History

Delphi Management Partners VIII’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$5.29M Hold
121,335
– – 3.82% 3
2021
Q2 		$5.07M Hold
121,335
– – 4.01% 3
2021
Q1 		$5.87M Hold
121,335
– – 4.06% 4
2020
Q4 		$11.9M Buy
+121,335
New +$10.6M 7.83% 3
2019
Q4 		$13.9M Buy
+121,335
New +$9.13M 10.94% 3

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Delphi Management Partners VIII's CALA Position: Q3 2021 in Review

Delphi Management Partners VIII held its Calithera Biosciences, Inc (CALA) position steady in Q3 2021 at 121,335 shares worth $5.29M. The position accounts for 3.82% of the portfolio, ranked #3.

Delphi Management Partners VIII first reported a position in CALA in Q4 2019 and has held it in 5 quarters since. The position peaked at $13.9M in Q4 2019. 66 funds tracked by Wall St. Rank hold CALA as of Q3 2021.

  • Delphi Management Partners VIII held 121,335 shares of Calithera Biosciences, Inc worth $5.29M as of Q3 2021.
  • Delphi Management Partners VIII left its Calithera Biosciences, Inc share count unchanged in Q3 2021.
  • Calithera Biosciences, Inc made up 3.82% of Delphi Management Partners VIII's portfolio in Q3 2021, its #3 holding.
  • Delphi Management Partners VIII first reported a position in Calithera Biosciences, Inc in Q4 2019 and has held it in 5 quarters since.
  • Delphi Management Partners VIII's Calithera Biosciences, Inc position peaked at $13.9M in Q4 2019.
  • 66 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2021.

Based on Delphi Management Partners VIII's 13F filing for Q3 2021, filed 15 Nov 2021.